Solvay Pharmaceuticals is seeking to in-license late stage or filed/marketed products to commercialize in the emerging markets including Brazil, Mexico, Turkey, China, India and Russia. More
Our Spanish based company is looking to acquire late stage or launched CNS products particularly in the areas of Parkinson disease, addiction, bi-polar disorder and schizophrenia. More
Unichem wishes to expand its current range of Neuro-Psychiatry (entire CNS area) formulations by partnering with companies and manufacturing / marketing their products under license, for the high potential Indian market. More
All rights reserved. Terms and Conditions | Contact us
